News
-
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
-
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
-
Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA
-
Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones
-
MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
-
Cerinnov Group: Suspension de cours à compter du 17 juin 2025
-
PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met
-
CEO Christian Grotholt remains major shareholder. Transfer of Mr. Grotholt’s 2G shares (29.6 %) to his own asset management company represents the only change.
-
ProSiebenSat.1 Executive and Supervisory Board welcome PPF’s elevated commitment and highlight monetization opportunity for shareholders
-
Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
-
Definitieve resultaten van de kapitaalverhoging
-
Final results of the capital increase
-
Final results of the capital increase
-
Eerste fase van het openbaar aanbod in het kader van een kapitaalverhoging is succesvol afgerond waarbij reeds werd ingeschreven op ongeveer 75,56% van de Nieuwe Aandelen Lancering van een versnelde private plaatsing van Scrips
-
First phase of the public offering in the framework of the capital increase has been successfully completed with about 75.56% of the New Shares already subscribed Launch of an accelerated private placement of Scrips